Genomic Testing in Brazil: Navigating Challenges and Harnessing Opportunities for Global Health Impact by Guilherme Harada, Tiago Biachi de Castria, Fabio Y. Moraes

Get full text

Central nervous system metastases of lung adenocarcinoma harboring EGFR-activating mutations: survival results from a multidisciplinary approach, including EGFR-TKIs by Guilherme Harada, Renata Rodrigues da Cunha Colombo Bonadio, Guilherme Nader Marta, Debora Zachello Recchimuzzi, Gilberto de Castro

Get full text

Updated Brazilian guidelines for the management of immune-related adverse events associated with checkpoint inhibitors - edition 2.0 by Rodrigo Ramella Munhoz, Clarissa Maria de Cerqueira Mathias, Guilherme Harada, Aknar Calabrich, Alberto Julius Wainstein, Andréia Cristina de Melo, Antonio Carlos Buzaid, Artur Katz, Carlos Gil Ferreira, Carlos Henrique dos Anjos, Clarissa Baldotto, Clarissa Maria de Cerqueira Mathias, Elimar Elias Gomes, Fernando Moura, Gilberto de Castro, Guilherme Harada, Guilherme Nader Marta, Gustavo dos Santos Fernandes, Luiza Dib Batista Bugiato Faria, Mariana Laloni, Paulo Marcelo Gehm Hoff, Rodrigo Ramella Munhoz, Romualdo Barroso-Sousa, Sergio Jobim de Azevedo, Vladmir Cláudio Cordeiro de Lima, William Nassib William

Get full text

A Phase II Study of Cabozantinib in Patients With MET-Altered Lung Cancers by Guilherme Harada, MD, Fernando C. Santini, MD, Clare J. Wilhelm, PhD, Rebecca W. Repetti, NP, Jason C. Chang, MD, Soo-Ryum Yang, MD, Yun-Te Lin, MSc, Khadeja A. Moses, BA, Christina Falcon, MPH, PMP, Michelle Goldstein, MSW, Alex Makhnin, MA, Michelle S. Ginsberg, MD, Andrew J. Plodkowski, MD, Mark G. Kris, MD, Alexander Drilon, MD

Get full text